Brief news reports on Tuberculosis

TB meningitis kills and damages nerve cells in brain through ‘overstimulation’

Study reveals how tuberculous meningitis (TBM) damages the nervous system along similar lines as chronic brain conditions such as Alzheimer’s.

Read More →

Webinar: Advancements in TB diagnostics

The Global Coalition of TB Activists (GCTA) and FIND will host a webinar on advancements in TB diagnostics on 26 September 2019.

Read More →

India makes commitment of US$22 million to Global Fund

NEW DELHI, 03 September 2019 - The Government of India today announced an increased commitment of US$22 million to the Global Fund for the next three years, highlighting India’s leadership in global efforts to end AIDS, TB and malaria as epidemics and to build stronger health systems.

Read More →

WHO Director-General calls on world leaders to support Universal Health Coverage High-Level Meeting

I have just returned from a visit to the Democratic Republic of the Congo with United Nations Secretary-General António Guterres to review the response to the Ebola outbreak. I was reminded once again that Ebola is just one symptom of a deeper problem: when people don’t have access to health services, or those services are of poor quality or don’t meet their needs, diseases can spread and lives can be lost.

Read More →

BioNTech announces new collaboration to develop HIV and TB programs

Mainz, Germany, September 4, 2019 – BioNTech SE, a clinical-stage biotechnology company focused on patient-specific immunotherapies for the treatment of cancer and other serious diseases, announced today that it has signed an agreement with the Bill & Melinda Gates Foundation (the Gates Foundation) to develop HIV and tuberculosis programs, further expanding the Company’s infectious disease portfolio. This partnership includes an initial equity investment of $55 million, which is expected to close within the next week. The funds will be used to develop preclinical vaccine and immunotherapy candidates to prevent HIV and tuberculosis infection as well as to lead to durable antiretroviral therapy-free remission of HIV disease. Total funding under the collaboration could reach $100 million through potential future grant funding from the Gates Foundation that would be used to underwrite the evaluation of these candidates in the clinic and support the initiation of new infectious disease projects.

Read More →

South-East Asia Regional Action Plan on the Programmatic Management of Latent Tuberculosis Infection launched at the 72nd Regional Committee

05 September 2019 | New Delhi: Health Ministers and experts from Member States of WHO South-East Asia Region began a week-long meeting in New Delhi this week to deliberate on priority public health issues and build on the recent momentum for elimination of communicable diseases.

Read More →

India must test new TB drug: Survivors appeal to Minister Harsh Vardhan

Tuberculosis activists have appealed to Union Health Minister Dr Harsh Vardhan requesting India to test a new TB drug, which has been approved by the USFDA.

Read More →

Vietnam: Health sector detects more than 50,000 new TB patients in the first six months of 2019

HÀ NỘI — More than 50,000 new tuberculosis (TB) patients have been discovered nationwide in the first six months of 2019.

Read More →

TB mutation discovery paves way for better treatments

PNAS publishes Rutgers New Jersey Medical school study: 'Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance'.

Read More →

Mobile phone intervention reduces TB treatment failure in Kenyan study

In Kenya, patients with tuberculosis who received daily text-based questions about treatment adherence and other mobile phone-based reminders were around two-thirds less likely to fail to complete treatment, according to findings published in The New England Journal of Medicine.

Read More →

Page 1 of 670 · Total posts: 10

1 2 Last→